IL153087A0 - Systems and methods for treating a mucosal surface - Google Patents
Systems and methods for treating a mucosal surfaceInfo
- Publication number
- IL153087A0 IL153087A0 IL15308701A IL15308701A IL153087A0 IL 153087 A0 IL153087 A0 IL 153087A0 IL 15308701 A IL15308701 A IL 15308701A IL 15308701 A IL15308701 A IL 15308701A IL 153087 A0 IL153087 A0 IL 153087A0
- Authority
- IL
- Israel
- Prior art keywords
- treating
- systems
- methods
- mucosal surface
- mucosal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21342000P | 2000-06-22 | 2000-06-22 | |
| US09/676,339 US6486168B1 (en) | 1999-01-08 | 2000-09-29 | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier |
| PCT/US2001/019979 WO2001097795A2 (en) | 2000-06-22 | 2001-06-22 | Systems and methods for treating a mucosal surface |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL153087A0 true IL153087A0 (en) | 2003-06-24 |
Family
ID=26908067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15308701A IL153087A0 (en) | 2000-06-22 | 2001-06-22 | Systems and methods for treating a mucosal surface |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1296644A2 (et) |
| JP (1) | JP2004508851A (et) |
| CN (1) | CN1273110C (et) |
| AU (1) | AU2001270081A1 (et) |
| BR (1) | BR0112386A (et) |
| CA (1) | CA2410208A1 (et) |
| CZ (1) | CZ20024175A3 (et) |
| EE (1) | EE200200705A (et) |
| HR (1) | HRP20021024A2 (et) |
| HU (1) | HUP0301233A2 (et) |
| IL (1) | IL153087A0 (et) |
| MX (1) | MXPA02012524A (et) |
| NO (1) | NO20026067L (et) |
| NZ (1) | NZ523073A (et) |
| PL (1) | PL361975A1 (et) |
| SK (1) | SK17812002A3 (et) |
| WO (1) | WO2001097795A2 (et) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211649D0 (en) | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
| ATE465753T1 (de) | 2002-10-21 | 2010-05-15 | Eisai Inc | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden |
| EP1686935A4 (en) * | 2003-10-22 | 2009-06-17 | Univ Cleveland Hospitals | METHOD AND DEVICE FOR APPLYING MEDICAMENTS TO INTERNAL TISSUE |
| US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939090A (en) * | 1996-12-03 | 1999-08-17 | 3M Innovative Properties Company | Gel formulations for topical drug delivery |
| SK287112B6 (sk) * | 1999-01-08 | 2009-12-07 | 3M Innovative Properties Company | Použitie zlúčeniny modifikujúcej imunitnú odpoveď pri liečení cervikálnej dysplázie |
-
2001
- 2001-06-22 JP JP2002503272A patent/JP2004508851A/ja not_active Abandoned
- 2001-06-22 IL IL15308701A patent/IL153087A0/xx unknown
- 2001-06-22 BR BR0112386-6A patent/BR0112386A/pt not_active Application Discontinuation
- 2001-06-22 EE EEP200200705A patent/EE200200705A/et unknown
- 2001-06-22 PL PL36197501A patent/PL361975A1/xx not_active Application Discontinuation
- 2001-06-22 CA CA002410208A patent/CA2410208A1/en not_active Abandoned
- 2001-06-22 HU HU0301233A patent/HUP0301233A2/hu unknown
- 2001-06-22 AU AU2001270081A patent/AU2001270081A1/en not_active Abandoned
- 2001-06-22 SK SK1781-2002A patent/SK17812002A3/sk not_active Application Discontinuation
- 2001-06-22 NZ NZ523073A patent/NZ523073A/xx unknown
- 2001-06-22 MX MXPA02012524A patent/MXPA02012524A/es active IP Right Grant
- 2001-06-22 EP EP01948622A patent/EP1296644A2/en not_active Withdrawn
- 2001-06-22 WO PCT/US2001/019979 patent/WO2001097795A2/en active IP Right Grant
- 2001-06-22 CZ CZ20024175A patent/CZ20024175A3/cs unknown
- 2001-06-22 CN CNB018115144A patent/CN1273110C/zh not_active Expired - Fee Related
-
2002
- 2002-12-17 NO NO20026067A patent/NO20026067L/no not_active Application Discontinuation
- 2002-12-20 HR HR20021024A patent/HRP20021024A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1437463A (zh) | 2003-08-20 |
| CA2410208A1 (en) | 2001-12-27 |
| AU2001270081A1 (en) | 2002-01-02 |
| WO2001097795A2 (en) | 2001-12-27 |
| EE200200705A (et) | 2004-08-16 |
| JP2004508851A (ja) | 2004-03-25 |
| HUP0301233A2 (hu) | 2003-08-28 |
| NO20026067D0 (no) | 2002-12-17 |
| HRP20021024A2 (en) | 2005-02-28 |
| CN1273110C (zh) | 2006-09-06 |
| CZ20024175A3 (cs) | 2003-06-18 |
| WO2001097795A3 (en) | 2002-04-04 |
| EP1296644A2 (en) | 2003-04-02 |
| PL361975A1 (en) | 2004-10-18 |
| NZ523073A (en) | 2005-04-29 |
| MXPA02012524A (es) | 2003-04-10 |
| SK17812002A3 (sk) | 2003-05-02 |
| NO20026067L (no) | 2003-02-17 |
| BR0112386A (pt) | 2003-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2364351B (en) | Surface fastener | |
| EP1253626A4 (en) | METHOD TO DRAW FINE PATTERN | |
| HK1038947B (zh) | 表面扣件 | |
| AU7090201A (en) | Method | |
| GB0009353D0 (en) | Method | |
| TW517535U (en) | Surface fastener | |
| AU2001290672A1 (en) | Side skirt for a surface treating apparatus | |
| GB0005867D0 (en) | Method | |
| IL153087A0 (en) | Systems and methods for treating a mucosal surface | |
| GB0123898D0 (en) | Method for treating objects | |
| GB0118883D0 (en) | Method for treating objects | |
| GB0014580D0 (en) | Appatarus and process | |
| GB0122810D0 (en) | Method for treating objects | |
| GB0123897D0 (en) | Method for treating objects | |
| GB0228183D0 (en) | Surface treatment tool | |
| GB0021747D0 (en) | Coating removal | |
| IL141300A0 (en) | A method and apparatus for flat surface treatment | |
| GB0007873D0 (en) | Method | |
| AU6082001A (en) | Method and system generating a contoured surface | |
| AU2002216177A1 (en) | Method for making a textile surface and resulting surface | |
| GB0107794D0 (en) | Embossed printing process and system | |
| AU2320000A (en) | Surface treating method | |
| EP1255617A4 (en) | COATING PROCESS | |
| GB0007872D0 (en) | Method | |
| IL135708A0 (en) | A method for improving the buyer-supplier contact and acquaintance |